MedPath

MABPRO, a.s.

MABPRO, a.s. logo
🇸🇰Slovakia
Ownership
Private
Established
2016-03-05
Employees
11
Market Cap
-
Website
https://www.mabprotx.com

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours

Phase 1
Not yet recruiting
Conditions
TNBC - Triple-Negative Breast Cancer
Non-small-cell Lung Carcinoma
Clear Cell Renal Cell Carcinoma Metastatic
Head and Neck Cancer
Mesothelioma, Malignant
Interventions
First Posted Date
2023-01-26
Last Posted Date
2023-03-15
Lead Sponsor
Mabpro, a.s.
Target Recruit Count
50
Registration Number
NCT05698238

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.